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hydroxy derivatives that serve as important endogenous signaling 
compounds (Kulas et al., 2008). CYPs-31A2 and -31A3 are required 
for the synthesis of lipids that are essential for embryonic devel-
opment in C. elegans (Benenati et al., 2009). Moreover, C. elegans 
CYP-22A1 (a.k.a. DAF-9) is known to make steroidal ligands that 
bind to the nuclear hormone receptor (NHR) DAF-12, and thereby 
regulate several developmental processes (Gerisch et al., 2001; Jia 
et al., 2002).
Several factors are involved in the regulation of C. elegans fat 
stores. Initially, fat is stored as triacylglycerols both in intestinal 
lysosome-related organelles and in lipid droplets found in intestinal 
and epidermal skin-like cells and mobilized by lipases (Schroeder 
et al., 2007; Mullaney and Ashrafi, 2008; Zhang et al., 2010). Fatty 
acids are used for energy in the process of beta-oxidation, which 
occurs in peroxisomes and mitochondria and whose end product 
is acetyl-CoA (Zhang et al., 2010). If beta-oxidation is impaired, 
the lipid droplets grow in size (Zhang et al., 2010). The nematode 
takes up fatty acids from the diet, primarily as triglycerides, and 
also synthesizes them de novo from acetyl-CoA (Watts and Browse, 
2002; Rappeleye et al., 2003). C. elegans can make all its neces-
sary unsaturated and long chain fatty acids from short chain fatty 
acids with desaturase and elongase enzymes, respectively, and does 
not need to obtain essential fatty acids from diet as humans do 
IntroductIon
Cytochromes P450 (CYPs) are mono-oxygenase enzymes that are 
found in most animals and plants. CYPs are known to oxidize a wide 
variety of exogenous compounds and also metabolize endogenous 
compounds such as steroids and fatty acids. From a toxicological 
perspective, understanding the endogenous functions of CYPs is 
important as the induction of these enzymes with xenobiotics is 
likely to affect the physiological processes involving CYPs (Amacher, 
2010). Several studies have shown that human, mouse, or rat CYPs 
hydroxylate or epoxidize metabolically important fatty acids such 
as linoleic acid (C18:2n6), alpha-linoleic acid (C18:3n3), arachi-
donic acid (C22:4n6), eicosapentaenoic acid (C20:5n3), adrenic 
acid (C22:4n6), and docosahexaenoic (C22:6n3) acid into bioactive 
compounds (reviewed in Konkel and Schunck, 2010). The nema-
tode Caenorhabditis elegans has 77 CYPs that can be classified into 
16 families plus five cyp pseudogenes. The physiological importance 
of C. elegans CYPs can be predicted in gene knockout or knock-
down studies. Knockout or RNA interference of cyp-35A2, -3, -4, 
or -5 leaves nematodes unable to accumulate fat normally (Ashrafi 
et al., 2003; Menzel et al., 2007). The CYP-35A family proteins are 
expressed in the intestine, which is a major location of fat stores 
(Ashrafi et al., 2003). In addition, C. elegans CYP-29A3 and CYP-
33E2 are known to metabolize eicosapentaenoic acid into epoxy and 
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(Watts and Browse, 2002; Kniazeva et al., 2004). C. elegans fatty 
acid desaturase and elongase genes are sequentially named fat-1 to 
7 and elo-1 to 8, respectively. Palmitic acid (C16:0) comes mainly 
from diet, whereas longer fatty acids are mostly synthesized from 
shorter ones (Watts, 2009). The enzymes responsible for fatty acid 
synthesis and degradation are expressed in the fat-storing cells and 
regulated by transcription factors such as NHR-49 (Van Gilst et al., 
2005a,b; Mullaney and Ashrafi, 2008).
Fatty acids can be metabolized into various signaling molecules 
(Konkel and Schunck, 2010). The fatty acid arachidonic acid is the 
molecular starting point of the arachidonic acid cascade, which 
includes the production of endocannabinoids. The endocannabi-
noids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are 
derived from membrane phospholipids through several routes 
(Awumey et al., 2008; Snider et al., 2010). In mammals, endo-
cannabinoids modulate neurotransmission, affect mood and 
behavior, and are involved in inflammation. Over activity of the 
endocannabinoid system has been also associated with obesity 
by acting through the cannabinoid receptor CB1 in several tis-
sues such as brain, adipose tissue, liver, pancreas, and skeletal 
muscle (Matias and Di Marzo, 2007; Maccarrone et al., 2010). 
CB1 antagonists alleviate obesity and improve the plasma lipid 
profile and insulin sensitivity in obese mice and rats (Cota et al., 
2009; Jourdan et al., 2010). Endocannabinoids are also found in 
C. elegans (Lehtonen et al., 2008) although this nematode lacks 
direct orthologs of CB1 and CB2 cannabinoid receptors (Elphick 
and Egertová, 2001; McPartland et al., 2006). C. elegans do have 
vanilloid receptors which can act as a receptor for AEA (Zygmunt 
et al., 1999). CYPs can metabolize AEA or its hydrolysis prod-
uct arachidonic acid (C20:4n6) into signaling molecules such as 
hydroxyeicosatetraenoic acids (HETEs), epoxyeicosatrienoic acids 
(EETs), and 2-epoxyeicosatrienoyl glycerols (2-EGs; Bornheim 
et al., 1995; Snider et al., 2007, 2008; Chen et al., 2008; Stark 
et al., 2008).
Among the most important challenges in toxicology as pro-
posed by Pelkonen (2010) is to develop testing systems to pre-
dict the toxicity potential of chemicals in an adequately reliable 
manner before humans or other living mammalian organisms 
have been exposed to them. In the current study, we demon-
strate the utility of a non-mammalian model to understand the 
role of a CYP subfamily 35A that metabolizes both endogenous 
and exogenous compounds. We aimed to identify the role of the 
CYP-35A subfamily in the regulation and maintenance of differ-
ent fatty acids molecules. While previous studies have suggested 
a role for CYP-35A family in fat storage, our goal was to take 
advantage of the unique genetic resources available in C. elegans 
and investigate fatty acid regulation at multiple levels. Using four 
different C. elegans CYP-35A family mutants, we assayed their 
ability to store fat. Fatty acid compositions were then measured 
to understand how the knockout of individual family members 
influenced the fatty acid profiles in whole animals. Moreover, 
endocannabinoid levels were measured in these mutants. Finally, 
gene expression changes were measured in fatty acid pathway 
genes to see how possible transcription changes might coincide 
with fatty acid changes. Using these multiple approaches, we 
observed a significant regulation of fatty acid molecules and 
changes in the transcriptional levels of genes controlling these 
molecules in cyp-35A family mutants. These results ultimately 
predict the regulation of fatty acid metabolism by members of 
the CYP-35A family.
MaterIals and Methods
PhylogenetIcs
The CYP protein sequences from H. sapiens and C. elegans were 
downloaded from the BioMart tool of the Ensembl database, 
and subsequently aligned with ClustalW2 and visualized as den-
drograms with HyperTree 1.0.0 (Sugen Inc.; Flicek et al., 2010). 
Labels were manually added. Sequence alignments (Figure S1 in 
Supplementary Material) were visualized using JalView.
WorM straIns and theIr groWth
The worm strains RB1788, cyp-35A1(ok2306; 1494 bp deletion 
including first four exons of the coding region; VC710, cyp-
35A2(gk317; 1245 bp deletion including four to seven coding 
exons and 3′UTR); RB1294, cyp-35A4(ok1393; ∼600 bp deletion); 
RB1613, cyp-35A5(ok1985; 367 bp deletion in three to four cod-
ing exon); and CB1370, daf-2(e1370; missense 1462 P–S) were 
received from the Caenorhabditis Genetics Center (Twin Cities, 
MN, USA). The nematodes were grown in standard conditions 
(Brenner, 1974).
Fat staInIng
Oil-Red-O (Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
was used to stain whole animals. The fatty acid staining was per-
formed as described by O’Rourke et al. (2009). Synchronized day-1 
adults were collected from plates and washed three times with 1× 
PBS. The worms were allowed to settle by gravity. To permeabi-
lize the cuticle, 120 μL of PBS and 120 μL of 2 × MRWB buffer 
(Modified Ruvkun’s Witches Brew; 160 mM KCl, 40 mM NaCl, 
20 mM Na
2
EGTA, 10 mM Spermidine HCl, 30 mM Na-PIPES pH 
7.4, 50% methanol) containing 2% paraformaldehyde was added. 
The 2× MRWB buffer used in our experiments contained an equal 
concentration of EDTA in place of Na
2
EGTA, and an equal con-
centration of HEPES in place of Na-PIPES. The nematodes were 
incubated at room temperature for 1 h with gently shaking and 
then washed with 1× PBS. To dehydrate the worms, 300 μL of 
60% isopropanol was added and the samples were incubated for 
15 min. The isopropanol solution was removed and 1 mL of 60% 
Oil-Red-O was added, as prepared in O’Rourke et al. (2009). The 
samples were incubated overnight with gentle shaking. The dye 
was removed and the nematodes were washed twice with 1× PBS, 
containing 0.01% Tween. The worms were resuspended in 1× PBS 
with 0.01% Tween, pipetted onto agarose pads and imaged with an 
Olympus AX70 fluorescence microscope (Olympus, Tokyo, Japan) 
with a UPlan Apo 60X/0.90 objective.
overall Fatty acId coMPosItIon
Fatty acid profiles were measured from CYP mutants and N2 
strains that were synchronized to the L4 stage by bleaching. 
A method similar to Watts and Browse (2000, 2002) was used 
for sample analysis. Briefly, to a 10-μL sample of worm pellet 
collected by centrifugation (∼350 g), 0.5 mL of 2.5% H
2
SO
4
 in 
methanol was added and samples were heated at 60°C for 1 h. 
After cooling the samples to room temperature, 1 mL of hexane 
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GTG ATC TTT CCT TCA TC-3′. The act-1 primer set was used 
as the internal control and fold changes were calculated using the 
2−(∆∆Ct) method (Livak and Schmittgen, 2001; Asikainen et al., 2010).
exPressIon oF cyp-35A genes In resPonse to FeedIng oF Fatty 
acIds
The triolein- and trielaidin-glycerides were purchased from 
Nu-Chek Prep (Elysian, MN, USA). Triolein-glyceride con-
tained the pure cis-18:1n9 fatty acid. Trielaidin contained the 
pure trans-18:1n9 fatty acid. After melting the triglyceride in a 
water bath (above 25°C for the cis-triolein, above 75°C for the 
trans-trielaidin), each oil was dispersed into hot agar by magnetic 
stirring drops of oil of a previously weighted volume, to achieve 
a final concentration of 25 μM in the agar. Plates were cooled 
quickly after pouring the agar, and then stored in a cool, dark 
place before use, in order to keep these triglycerides evenly dis-
tributed throughout the solidified agar. Higher concentrations of 
triglycerides eventually resulted in the appearance of oil droplets 
on the agar surface. Gravid worms grown on NGM agar were col-
lected and embryos obtained by bleaching. Embryos were then 
grown on triglyceride plates and collected for analyses at the L4 
stage (∼48–56 h later).
Gene expressions of the cyp-35A1, cyp-35A2, cyp-35A4, and 
cyp-35A5 genes in wild-type nematodes with and without feed-
ing of fatty acids were measured as described in Section “Gene 
Expression of Fatty Acid Synthesis and Beta-Oxidation Genes.” The 
oligo primers were purchased from Oligomer (Helsinki, Finland). 
Their sequences were: cyp-35A1 forward, 5′-CGG CAG AAG CCG 
TTA AAA G-3′; cyp-35A1 reverse, 5′-TGA CCA GTC ATC CAC 
AAA TCG-3′; cyp-35A2 forward, 5′-TTC TCC CTT CAA GCA 
TTT AGG A-3′; cyp-35A2 reverse, 5′-ATC GAA AAA TTC AGA 
GGC ATG T-3′; cyp-35A4 forward, 5′-ACC AAA TCA AGT CTG 
GGA GGT A-3′; cyp-35A4 reverse, 5′-GCC TGT TAT CCA TAA 
ATC ACC AA-3′; cyp-35A5 forward, 5′-TAC CTT TGG ACA ACT 
GGT GGT A-3′; cyp-35A5 reverse, 5′-AAG TCT CAT AAT CGG 
CAA TGC T-3′.
endocannabInoIds
The endocannabinoids were measured with liquid chromatogra-
phy coupled to an electrospray-ionization triple quadrupole mass 
spectrometer (ESI–LC/MS/MS; Lehtonen et al., 2008). Briefly, 
synchronized fourth larval stage (L4) nematodes were collected 
from plates with M9 buffer. Twenty microliters of vortexed sample 
was transferred to an Eppendorf tube. One milliliter of MeOH 
was added and the samples were homogenized with a Soniprep 
150 homogenizer (MSE Ultrasonic Disintegrator, MSE Scientific 
Instruments, Manor Royal, Crawley, Sussex, England). Lipids were 
extracted by adding 2 mL of CHCl
3
 and 1 mL of H
2
O, followed by 
centrifugation at 1500 × g and incubation at 10°C for 10 min to 
separate the phases. The aqueous upper layer was removed and 
the organic layer transferred to a screw-capped test tube. The lipid 
extraction was repeated on the obtained sample. The sample was 
evaporated to dryness under N
2
 and the residue was reconstituted 
in 50 μL of ice-cold ACN. The residue was allowed to dissolve 
for 5 min, after which 20 μL of H
2
O was added. The sample was 
centrifuged at 12000 × g and 10°C for 10 min and transferred to 
an HPLC sample vial.
and 1.5 mL of H
2
O were added and the mixture was vortexed. 
The phases were separated and the organic phase was evaporated 
to dryness under nitrogen at room temperature. The residue 
was dissolved in 100 μL of hexane for analysis. Fatty acid methyl 
esters (FAMEs) were analyzed by gas chromatography coupled 
to electron ionization mass spectrometry (Agilent Technologies, 
Palo Alto, CA, USA) using a bis-cyanopropyl capillary column 
(100 m × 0.25 mm i.d.) with 0.20 μm film thickness (SP-2560, 
Supelco, Bellefonte, PA, USA) for analysis with pulsed split injec-
tion (1 μL). The oven temperature was held at 180°C for 2 min, 
then increased to 240°C at 3°C/min rate and held at 240°C 
for 8 min. The carrier gas was helium with constant flow of 
21 cm/s. The temperatures of the MS transfer line heater, ioniza-
tion source, and quadrapole were maintained at 250, 230, and 
150°C, respectively. In the GC/EI–MS full scan and the selected 
ion monitoring modes were used for qualitative and quantitative 
analysis of FAMEs, respectively.
gene exPressIon oF Fatty acId synthesIs and beta-oxIdatIon 
genes
Total RNA was extracted from four separate L4 larval stage 
C.  elegans cultures with RiboPure™ Kit (Ambion, Austin, TX, USA). 
For each replicate, 0.5 μg of total RNA was reverse transcribed in 
a volume of 19 μL using 2 μL dNTP Mix (10 mM each, Fermentas 
Life Sciences, Vilnius, Lithuania), 4 μL 5× Reaction Buffer, and 
1 μL RevertAid Minus M-MuLV Reverse Transcriptase (200 u/μL; 
Fermentas Life Sciences). The RT reactions were diluted 1:6 with 
nuclease free H
2
O. Real-time PCR was performed in a volume of 
25 μL consisting of 12.5 μL of Maxima™ SYBR Green/ROX qPCR 
Master Mix (Fermentas Life Sciences), 0.2 μM (final concentration) 
of forward and reverse primers each in nuclease free H
2
O and 2.5 μL 
of the diluted RT reaction. The PCR reactions were performed in 
a MyiQ Single Color Real-Time PCR Detection System (Bio-Rad 
Life Sciences, Hercules, CA, USA). The oligo primers were pur-
chased from Oligomer (Helsinki, Finland) and sequences were: 
act-1 forward, 5′-TCG GTA TGG GAC AGA AGG AC-3′; act-1 
reverse: 5′-CAT CCC AGT TGG TGA CGA TA-3′; fat-1 forward, 
5′-CGC CTT CTC ACC ACT CTT CT-3′; fat-1 reverse, 5′-TCC ACA 
CGT GTC CAT GAT CT-3′; fat-2 forward, 5′-TCC CGG CTC TTC 
GAG ACT AC-3′; fat-2 reverse, 5′-GAA TAG TCG CAG AGG ACA 
AAG G-3′; fat-3 forward, 5′-GAG GAG GCC TTT TGA TTG CT-3′; 
fat-3 reverse, 5′-TTG AAG AGC GGC GAA GTT-3′; fat-4 forward, 
5′-ACA TCC AGG TGG TAG TGC AA-3′; fat-4 reverse, 5′-CTG 
GGA TCT CTG GTT CTT GTG-3′; fat-5 forward, 5′-CGC TCA 
TAT GGG ATG GTT GT-3′; fat-5 reverse, 5′-CAG GGC GAA GCA 
GAA GAT T-3′; fat-6 forward, 5′-GCC CAG AGA CGC AAT ATC 
TC-3′; fat-6 reverse, 5′-CAG CAA AGA GAG CCA CGT TA-3′; fat-7 
forward, 5′-GCA GCC ATT GGA CTT TAC GA-3′; fat-7 reverse, 
5′-GAT GGG CTC CAG CTG TGA TA-3′; elo-1 forward, 5′-GAA 
TTT CCC TGA CGC AGA AG-3′; elo-1 reverse, 5′-GTT CCG AAC 
ACA ACG ACC AT-3′; elo-2 forward, 5′-CCA GTG GCA AAG TTC 
ATC AC-3′; elo-2 reverse, 5′-TCC TCC GAT CGA TAG CAC AT-3′; 
elo-5 forward, 5′-TTG GAT CTT CCT TTG GGT TAT CT-3′; elo-5 
reverse, 5′-TCA TGG TAG CAG ACA AGA GCA TA-3′; elo-6 for-
ward, 5′-CTC AAT GGC ATA TGT TGT CGT TA-3′; elo-6 reverse, 
5′-TCC GAG AGT TGA GAA AAT AGC AA-3′; acs-2 forward, 
5′-TTG GAC TAT GTC GCT GAT GC-3′; acs-2 reverse, 5′-GCG 
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Oil-Red-O staining as the wild-type (Figures 2M–R). The cyp-35A5 
had some Oil-Red-O staining in the intestine but visibly less than 
wild-type (Figures 2S–U).
Fatty acId coMPosItIon and endocannabInoId changes In 
cyp-35A Mutants
The overall fatty acid compositions of CYP mutants did not 
alter dramatically, although modest but significant changes were 
observed (Figure 3). Compared to wild-type animals, cyp-35A1 
Anandamide and 2-AG were quantified by liquid chromatog-
raphy (Agilent 1200 series rapid resolution LC system, Agilent 
Technologies, D-Waldbronn) coupled with an ESI triple quadru-
pole mass spectrometer (Agilent 6410 triple quadrupole LC/MS, 
Agilent Technologies, Palo Alto, CA, USA). Ten microliters of sample 
solution was injected onto a reversed phase HPLC column (Zorbax 
Eclipse XDB-C18 rapid resolution HT 2.1 mm × 50 mm, 1.8 mm, 
Agilent Technologies, Palo Alto, CA, USA) using an isocratic mobile 
phase consisting of 55% of 0.1% HCOOH in ACN and 45% of 0.1% 
HCOOH in H
2
O, delivered at 200 μL/min. Column temperature 
was maintained at 40°C and the autosampler tray temperature was 
set at 10°C. The following ionization conditions were used: ESI, 
positive-ion mode; drying gas (N2) temperature, 300°C; drying 
gas flow, 10 L/min; nebulizer pressure, 50 psi, and cap. voltage, 
4000 V. Detection was performed using multiple reaction moni-
toring (MRM) with the following transitions: m/z 348 → 62 for 
AEA, m/z 356 → 63 for AEA-d
8
, m/z 379 → 287 for 2-AG, and 
387 → 294 for 2-AG-d
8
. Fragmentor voltage and collision energy 
for AEA, AEA-d
8
, 2-AG, and 2-AG-d
8
 were 120 and 10 V, 120 and 
12 V, 130 and 8 V, and 125 and 10 V, respectively. Dwell time was 
100 ms for each transition, and mass resolution for MS1 and MS2 
quadrupoles were 2.4 and 1.2 FWHM, respectively, for AEA, and 
0.7 and 0.7 FWHM, respectively, for AEA-d
8
, 2-AG, and 2-AG-d
8
. 
Deuterated internal standards, AEA-d
8
 and 2-AG-d
8
, were used for 
quantification.
results
PhylogenetIcs
The C. elegans CYP-35 family is most closely related to C. elegans 
CYP-34 family. The closest human CYP families to C. elegans 
CYP-35 are CYP-1 (Hs1) and CYP-2 (Hs2). However, members 
of the major human families CYP-1 and CYP-2 clearly share more 
similarities with each other than with C. elegans families. Human 
CYP-3 (Hs3) and CYP-4 (Hs4) families are more closely related to 
C. elegans families other than CYP-35 (Figure 1).
Within the C. elegans CYP-35A subfamily the peptides CYP-
35A2 and -3 are the most similar (Figure 1). CYP-35A1 is the most 
different. Subfamilies B, C, and D are not as expanded as subfamily 
A. The amino acid sequences of the CYP-35A proteins are very simi-
lar at the N terminus from amino acid 0 to 100, and also from amino 
acid 300 to 400 with minor amino acid differences. CYP-35A1 is 
missing a 38 amino acid sequence that the other CYP-35A proteins 
have in the middle of the peptide chain (amino acids 254–291), and 
it has additional amino acids closer to the C terminus (Figure S1 
in Supplementary material).
Fat staInIng In cyp-35A Mutants
Wild-type N2 strain animals feeding on bacteria show abundant 
Oil-Red-O staining, particularly in the intestine and mature oocytes 
(Figures 2A–C). Animals starved for a day show loss of staining, in 
the intestine and less in oocytes (Figures 2D–F). The daf-2 mutant, 
as a positive control, showed heavy fat staining in the intestine 
(Figures 2G–I). In contrast, the cyp-35A1 mutant showed light 
Oil-Red-O staining in the intestine, mainly in the anterior part, and 
oocytes (Figures 2J–L), resembling the starved wild-type that also 
had staining in the eggs but not visible amounts in the intestine. 
The cyp-35A2 and cyp-35A4 mutants had about the same level of 
FiguRe 1 | Phylogenic clustering diagram of Human (Hs) and C. elegans 
(Ce) cytochrome P450 genes. CYP protein sequences were downloaded 
from public databases and aligned as described in Section “Materials and 
Methods.” CYP family names are shown at the base of the tree and individual 
proteins are shown at the end of the branches. Location of the C. elegans 
CYP-35A family is indicated by the bolded line.
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mutants had significantly higher levels of C18:1n7 and lower 
C18:2n6c. All four mutants had higher relative amounts of 
C18:1n7 than the wild-type (Figure 3).
mutants had significantly higher C16:0, C18:1n7, C18:3n6, and 
C20:4n6, while having significantly lower levels of C18:2n6c, 
C20:4n3, and C20:5n3 fatty acids. In concordance, cyp-35A5 
FiguRe 2 | Fat content visualized by Oil-Red-O staining. N2, starved N2, 
daf-2, cyp-35A1, cyp-35A2, cyp-35A4, cyp-35A5. Animals were grown and 
treated as described in Materials and Methods. Staining was performed on 
populations of day-1 adult animals and photographed using transmitted light 
microscopy at 200× magnification. Panels shown are three typical fields per 
mutant or treatment. (A–C), wild-type; (D–F), wild-type starved; (g–i), daf-2 
mutant; (J–L), cyp-35A1 mutant; (M–O), cyp-35A2 mutant; (P–R), cyp-35A4 
mutant; (S–u), cyp-35A5 mutant.
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fat-3, fat-5, fat-6, fat-7, elo-1, and elo-6 were significant (p < 0.05). 
In a different cyp-35A1(ok1414) mutant allele strain, only fat-2 was 
significantly over-expressed, but all the measured genes were found 
in somewhat higher amounts than in the wild-type (data not shown). 
In the cyp-35A5 mutant many fatty acid synthesis genes seemed to be 
under-expressed, although only the changes in fat-1 and fat-3 were 
significant. The fatty acid beta-oxidation gene acs-2 was slightly (1.7-
fold) over-expressed in the cyp-35A2 mutant and under-expressed 
(fold change 0.8) in the cyp-35A5 mutant (data not shown).
A map of the fatty acid metabolism pathway was then drawn 
and significant changes in gene expression and fatty acids were 
placed onto the map. The top part of the map involving C16:0, 
C16:1, C18:0, C18:1n7 appears to be concordant: gene expression 
increases in fat-5 for the cyp-35A1 mutant are in agreeement with 
increases in C18:1n7. The middle portion of the map including 
C18:1n9, C18:2n6, C18:3n3,C18:3n6, C18:4n3 does not appear to 
be concordant. The bottom part of the map including C20:3n6, 
C20:4n3, C20:4n6, and C20:5n3 appears concordant, particularly 
the increases in C20:4n6 due to increases in elo-1 expression in 
cyp-35A1 animals (Figure 5B).
exPressIon oF cyp-35A subFaMIly genes In resPonse to FeedIng 
oF cis- and trans-c18:1n9
In order to determine whether or not cyp-35A family genes respond 
to fat feeding, we fed wild-type animals oleic or elaidic triglycerides, 
which are the cis- and trans-triglycerides of C18:1n9, respectively. 
In wild-type C. elegans, the cyp-35A1 gene was not responsive to 
fat feeding, while cyp-35A2, cyp-35A4, and cyp-35A5 significantly 
decreased expression (Table 1). There was no differentiation when 
animals were fed cis- or trans-isomers of these triglycerides (Table 1).
dIscussIon
PhylogenetIcs
Caenorhabditis elegans CYP peptide sequences clustered similarly 
as in an early phylogenetic study by Gotoh (1998). The relatively 
large number of paralogs in the cyp-35 family indicates that these 
The endocannabinoid AEA was found to be 4.6-fold higher in 
the cyp-35A5 mutant than in the wild-type (Figure 4). 2-AG levels 
were not significantly altered in any of the mutants.
gene exPressIon changes oF Fatty acId synthesIs genes and 
acs-2
In the cyp-35A1(ok2306) mutant many genes required in the synthesis 
of long chain fatty acids appeared to be expressed in 2–3.5 times 
higher amounts than in wild-type (Figure 5A). The increases in fat-2, 
FiguRe 3 | Fatty acid composition of cyp-35A1, -2, -4, and -5 mutants. 
Animals were synchronized to the L4 larval stage and assayed for fatty acids 
as described in Materials and Methods. Histograms represent percentages of 
the total amount of the fatty acids measured. Error bars represent SD. *t-test 
p-value < 0.05, **t-test p-value < 0.01, ***t-test p-value < 0.001, compared to 
wild-type N2. Some additional fatty acids were included in the assay but not 
included in the figure due to low concentrations (<1 nmol %) or lack of change.
FiguRe 4 | L4 stage wild-type and mutant animals were collected and 
assayed for the endogenous cannabinoids. Fold changes of anandamide 
(AEA) and 2-arachidonoylglycerol (2-AG) amounts ± SEM in cyp-35A mutants 
are shown. ***t-test p-value < 0.001.
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CYP-1 and CYP-2, suggesting their relatively recent evolution prob-
ably in response to xenobiotic challenges. Those families were clus-
tered together with several C. elegans CYP families (such as cyp-35 
family), similarly as in fish and insects (Nelson, 2003; Feyereisen, 
2006), indicating an evolutionally old distinction between the major 
CYP clades, probably due to their early separated endogenous func-
tions, which in human include metabolism of fatty acid derivatives 
(Arnold et al., 2010). In the genome, the cyp-35 genes are located 
in a cluster on chromosome V, adjacent to each other and cyp-34 
family genes. CYPs whose genes appear in clusters are more likely 
to be involved in xenobiotic metabolism than CYPs whose genes 
reside isolated from other cyp genes in the genome (Thomas, 2007). 
The closest human counterparts of the CYP-35A family, the highly 
diverse families CYP-1 and CYP-2, metabolize both exogenous and 
endogenous compounds, the latter including omega-3 and -6 fatty 
acids and their derivatives (Schwarz et al., 2004; Fer et al., 2008; 
enzymes may function at least partly in xenobiotic metabolism 
(Thomas, 2007). This is also supported by studies showing that 
the cyp-35A family genes are induced by a number of xenobiotics 
(Menzel et al., 2001, 2005; Reichert and Menzel, 2005; Roh et al., 
2007; Chakrapani et al., 2008). Further, as shown in phylogenetic 
comparisons between fish, insect, and human CYPs (Nelson, 2003; 
Feyereisen, 2006), we observed high similarities with human  families 
FiguRe 5 | (A) Changes in the expression levels of fatty acid synthesis genes 
(fold change compared to wild-type ± SEM). *t-test p-value < 0.05, **t-test 
p-value < 0.01, ***t-test p-value < 0.001. (B) Schema of the synthesis of fatty 
acids and the enzymes involved.  = fatty acid percentage or gene expression 
increased in cyp-35A1 mutant,  = fatty acid percentage or gene expression 
decreased in cyp-35A1 mutant,  = fatty acid percentage or gene expression 
increased in cyp-35A5 mutant,  = fatty acid percentage or gene expression 
decreased in cyp-35A5 mutant.
Table 1 | Fold change ± SeM of the expression of cyp-35A family genes.
 cyp-35A1 cyp-35A2 cyp-35A4 cyp-35A5
N2 cis/no feeding 0.93 ± 0.19 0.66 ± 0.05* 0.53 ± 0.05*** 0.63 ± 0.05*
N2 trans/no feeding 1.12 ± 0.61 0.38 ± 0.05** 0.56 ± 0.10* 0.50 ± 0.09*
Significances of the alterations were determined with Student’s t-test. *p < 0.05, 
**p < 0.01, ***p < 0.001.
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in composition could be diluted. Alternatively, we were not able 
to analyze the distribution of fatty acids in different subcellular 
fractions. Indeed, major changes in fatty acid composition pro-
files are typically only seen in C. elegans mutants lacking fatty acid 
desaturation and elongation enzymes (Watts and Browse, 2002; 
Kniazeva et al., 2004). Studies detailing the role of transcription 
factors regulating the fatty acid synthesis and metabolism pathway 
genes see more modest changes, in agreement with the present 
study (Van Gilst et al., 2005a,b; Taubert et al., 2006; Aarnio et al., 
2010). Alternatively, these small changes might reflect the strong 
metabolic drive to maintain fat homeostasis.
In contrast, sharply elevated levels of the endocannabinoid AEA 
were found in the cyp-35A5 mutant. AEA increases weight gain and fat 
content in mammals (Matias and Di Marzo, 2007; Maccarrone et al., 
2010). Thus, the elevation of AEA may be a homeostatic response 
to decreased fat content in cyp-35A5 mutant animals. AEA can be 
made of phospholipids containing arachidonic acid (C20:4n6; Snider 
et al., 2010). Consistent with this, we observed significant increases 
in C20:4n6 for cyp-35A1 and A5 mutants. In support of a prominent 
role of CYPs in controlling signaling lipid synthesis, pioneering work 
by Menzel and colleagues demonstrate the role of C. elegans CYPs 
in metabolizing eicosapentaenoic acid and arachidonic acid, whose 
metabolic products could serve as secondary messengers in various 
signaling pathways (Kulas et al., 2008). Alternatively, CYP-35A5 could 
directly metabolize AEA. Support for this hypothesis comes from ear-
lier studies, however not in C. elegans, demonstrating that mammalian 
CYPs can metabolize AEA and its hydrolysis product arachidonic 
acid into bioactive compounds (HETEs and EETs; Bornheim et al., 
1995; Snider et al., 2007, 2008; Chen et al., 2008; Stark et al., 2008), 
some of which can activate cannabinoid receptors (Chen et al., 2008).
If cyp-35A5 mutants respond homeostatically to lower fats 
by increasing endocannabinoids, why do cyp-35A1 mutants not 
respond in the same manner? First, lack of the CYP-35A1 protein 
appears to result in lower overall fat (Figure 2) and increases in both 
fatty acid desaturation and elongation gene expressions (Figure 5). 
These appear to suggest a role for CYP-35A1 in maintaining con-
stitutive fat levels. In support of this hypothesis, cyp-35A1 gene 
expression does not respond to fat feeding while other cyp-35A1 
family members do (Table 1). Moreover, endocannabinoid levels 
appear normal in cyp-35A1 mutants.
conclusIon
Taken together, these results show that the CYP-35A subfamily plays a 
part in the dynamic regulation of the variety of different fatty acid mol-
ecules in C. elegans. The lack of CYP-35A1 and CYP-35A5 decreases 
intestinal fat stores. However, the mechanism by which this is achieved 
may differ, as the transcriptional levels of fatty acid metabolism genes 
differ dramatically between these two mutants. Moreover, CYP-35A1 
does not appear to respond transcriptionally to fat ingestion, whereas 
CYP-35A5 and other CYP-35 members consistently decrease gene 
expression. The lack of CYP-35A5 affects AEA levels. Taken with the 
modest changes in fatty acid profiles, these results suggests a stronger 
role for CYP-35A members in regulating fatty acid derived signaling 
molecules, rather than structural fatty acids, in C. elegans. In summary, 
these results demonstrate an important role for CYP-35A members 
in regulating fat metabolism and signaling molecules in C. elegans. 
These results thus provide a framework for future mechanistic  studies 
Arnold et al., 2010). Nematodes C. briggsae and C. remanei have 
CYP-35A subfamilies but they are not as expanded as the C. elegans 
CYP-35A subfamily (data not shown). Vertebrates or insects do not 
have a CYP-35 family suggesting that CYP-35 enzymes may have a 
nematode-specific endogenous function.
cyp-35A1 and cyp-35A5 Mutants have a dePleted Fat content as 
vIsualIzed by oIl-red-o staInIng
The lack of functional CYP-35A1 and CYP-35A5 leads to decreases in 
intestinal fat (Figure 2). This suggests that these CYPs are necessary, 
but not sufficient to maintain fat storage. The molecular mechanism 
by which these CYPs act may be complex. Genome-wide RNAi stud-
ies in C. elegans have revealed 305 gene inactivations that reduce body 
fat (Ashrafi et al., 2003). In addition to CYPs, signal transduction 
enzymes, receptors, transporters, and energy metabolism enzymes 
were found. Among the best studied fat storage regulators in C. 
elegans is NHR-49, a NHR, which has been shown to influence the 
regulation of 13 genes involved in energy metabolism (Van Gilst et al., 
2005a,b). Several of these (fat-5, fat-6, and fat-7) overlap with those 
found to be regulated in this study, which suggests that CYPs and 
NHRs may share common pathways in the regulation of fat storage.
In earlier fat staining experiments with Nile Red, the cyp-
35A2(gk317), cyp-35A3, cyp-35A4(ok1393), and cyp-35A5(ok1985) 
mutants were deficient in fat accumulation, but the cyp-35A1(ok1414) 
mutant was normal (Menzel et al., 2007). The study of Menzel et al. 
(2007) used a different allele of cyp-35A1 compared to our study, but 
the other strains used were the same. The reason for the different 
results could be the stains used. The Nile Red dye stains the lysosome-
related organelles but not the lipid droplets (O’Rourke et al., 2009), 
and these differences could explain our results, as we used Oil-Red-O. 
Recently, other laboratories have used Oil-Red-O in place of Nile Red 
(Soukas et al., 2009; Horikawa and Sakamoto, 2010).
We investigated CYP-35A subfamily members -1, -2, -4, -5, as 
these mutants were readily available. A previous RNAi study showed 
that knockdown of cyp-35A3 and A5 reduced the fat content of 
wild-type animals (Ashrafi et al., 2003), possibly via cyp-35A2 and 
cyp-35A4 as secondary targets of the cyp-35A3 RNAi construct. The 
knockdown of the entire cyp-35A subfamily has an interesting pheno-
type: when cyp-35A1, cyp-35A3, cyp-35A5, and cyp-35C1 are silenced 
with RNAi in a cyp-35A2, cyp-35A4 double mutant background, the 
nematodes are more resistant to the reproductive toxicity of PCB52 
than wild-type (Menzel et al., 2005). PCB52 is known to induce these 
genes (Menzel et al., 2001) and also increase the storage of fat, which 
may at least partially be the mechanism of its toxicity (Menzel et al., 
2007). The silencing of cyp-35A genes with RNAi does not cause 
abnormalities in fertility, morphology, embryonic lethality, mater-
nal sterility, larval lethality, growth, sterility of progeny, larval arrest, 
postembryonic development, or lethality (Kamath et al., 2003; Rual 
et al., 2004; Menzel et al., 2005; Sonnichsen et al., 2005).
overall Fatty acId coMPosItIons and anandaMIde are altered 
In cyp-35A Mutants
The relative amounts of different fatty acids are affected in the cyp-
35A subfamily mutants, although modestly. Indeed, most changes 
in fatty acid composition were only on the order of a few percent. 
The lack of large changes could be due to factors such as sampling, 
as whole animals were used for analysis and large local changes 
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